ABEO
Abeona Therapeutics Inc
NASDAQ: ABEO · HEALTHCARE · BIOTECHNOLOGY
$5.34
-0.37% today
Updated 2026-04-29
Market cap
$303.75M
P/E ratio
5.29
P/S ratio
52.19x
EPS (TTM)
$1.01
Dividend yield
—
52W range
$4 – $8
Volume
1.2M
Abeona Therapeutics Inc (ABEO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
1,223.00%
Operating margin
-422.70%
ROE
70.10%
ROA
-34.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $550.00M | $-12.87M | 100.00% | -0.94% | -2.34% |
| 2007 | $57000.00 | $-21.74M | 100.00% | -12,105.26% | -38,147.37% |
| 2008 | $291000.00 | $-31.43M | 100.00% | -5,812.71% | -10,801.03% |
| 2009 | $352000.00 | $-17.34M | 100.00% | -2,748.86% | -4,926.14% |
| 2010 | $481000.00 | $-7.54M | 70.89% | -1,612.68% | -1,566.94% |
| 2011 | $1.85M | $-2.53M | 34.20% | -426.19% | -137.01% |
| 2012 | $4.40M | $-10.53M | 93.94% | -98.00% | -239.15% |
| 2013 | $2.04M | $4.45M | 93.88% | -186.29% | 217.87% |
| 2014 | $925000.00 | $-26.78M | 100.00% | -338.49% | -2,894.92% |
| 2015 | $1.04M | $-14.53M | 100.00% | -1,783.27% | -1,396.73% |
| 2016 | $889000.00 | $-21.87M | -1,098.54% | -2,686.28% | -2,460.40% |
| 2017 | $837000.00 | $-27.32M | -1,929.75% | -3,325.69% | -3,263.92% |
| 2018 | $3.00M | $-56.67M | -1,190.79% | -1,940.16% | -1,890.29% |
| 2019 | $0.00 | $-76.28M | — | — | — |
| 2020 | $10.00M | $-84.23M | 100.00% | -814.20% | -842.34% |
| 2021 | $3.00M | $-84.94M | 100.00% | -2,994.53% | -2,831.20% |
| 2022 | $1.41M | $-39.70M | 68.18% | -3,600.78% | -2,807.36% |
| 2023 | $3.50M | $-54.19M | 54.14% | -1,346.71% | -1,548.23% |
| 2024 | $0.00 | $-63.73M | — | — | — |
| 2025 | $5.82M | $71.18M | 73.68% | -1,536.91% | 1,223.08% |